← FDA DRUG APPROVALS

FDA ANDA · ANDA084343

KENALOG

Sponsor: DELCOR ASSET CORP

APPLICATION
ANDA084343
TYPE
ANDA
ORIGINAL APPROVAL
1974-07-16
LATEST ACTION
1992-11-09
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Discontinued

Products

KENALOGDiscontinued
TRIAMCINOLONE ACETONIDE 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · LOTION · TOPICAL
KENALOGDiscontinued
TRIAMCINOLONE ACETONIDE 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · LOTION · TOPICAL

Approval history

1992-11-09Manufacturing (CMC) · Supplement 31AP
1983-06-28Manufacturing (CMC) · Supplement 25AP
1983-05-05Manufacturing (CMC) · Supplement 24AP
1982-12-01Manufacturing (CMC) · Supplement 23AP
1982-06-21Manufacturing (CMC) · Supplement 22AP
1981-12-21Manufacturing (CMC) · Supplement 17AP
1981-12-21Manufacturing (CMC) · Supplement 21AP
1981-12-21Manufacturing (CMC) · Supplement 18AP
1974-07-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →